E

Earli

Biotech platform enabling early cancer detection

Senior Scientist - Bio AI

Quantitative Biology & BiostatisticsConfirmed live in the last 24 hours
Full-timeRedwood City, CA, USA$205k - $235k /yrIn-person

About the Job

Requirements

  • A Master’s or PhD degree in a relevant field, such as bioengineering, computer science, or data science, and at least 3 years of hands-on experience applying artificial intelligence and machine learning to genomic or bioinformatic data using state-of-the-art generative AI models.
  • Demonstrated hands-on expertise in model training, fine-tuning, and in-silico evaluation; deep direct expertise in developing generative AI models trained on large biological datasets is required.
  • Competence in analyzing large, complex empirical datasets, including massively parallel reporter assay data and multimodal omics data.
  • Familiarity and prior experience collaborating with wet-lab scientists to generate and curate high-throughput screening data on large libraries of DNA or RNA sequences.
  • Proficiency in routine bioinformatic analyses, including differential gene expression, ATAC-seq, and RNA-seq analysis.
  • Expert-level coding skills in Python and R.
  • Basic knowledge of fundamental cancer biology.
  • Verbal and written communication and interpersonal skills.
  • Ability to multitask, manage multiple projects simultaneously, and work effectively within a team.
  • Ability to think independently and integrate into a high-achieving team environment.

Responsibilities

  • Leverage machine learning, bioinformatics, and high-throughput assay data to design cancer-specific synthetic promoters and novel genetic medicines for Earli’s clinical pipeline.
  • Train generative AI models to design genetic medicines using Earli’s proprietary massively parallel reporter assay data and external datasets.
  • Contribute to wet-lab experimental design and data evaluation to benchmark AI model performance against ground-truth wet-lab data and create a rapid iteration loop.
  • Perform routine computational analyses of massively parallel reporter assay and other large experimental datasets using existing packages and bespoke analyses as needed.
  • Provide accessible interfaces, such as Shiny apps, for routine team data analysis, including RNA-seq profiling.
  • Perform routine bioinformatic analyses on multimodal omics data, including RNA-seq, single-cell RNA-seq, ATAC-seq, proteomics, and phosphoproteomics, using individual and integrated multi-omic machine-learning pipelines to identify dysregulated targets and pathways in selected cancer indications.
  • Deploy code and execute it on Earli’s infrastructure hosted by cloud service providers such as Google Cloud Platform, adapting engineering as needed.
  • Help develop and work within budgets for graphics processing unit usage and compute.

Desired Qualifications

  • Deep expertise in cancer omics, biomarkers, targets, and pathways is preferred.
  • High-quality publications in the area of generative AI models trained on large biological datasets are preferred.

About the Company

Earli

Biotech platform enabling early cancer detection

Earli develops a cancer diagnostic platform that uses synthetic biology to create Synthetic Bioclassifiers. These genetic constructs enter cells and, if a cell is cancerous, activate to make the cell produce a biomarker that is released into the bloodstream for detection. The system is programmable to distinguish cancerous from healthy cells, addressing the limits of traditional liquid biopsies by prompting cancer cells to reveal themselves. It plans to commercialize this platform through partnerships with healthcare providers and pharmaceutical companies, with Accenture as a strategic investor.

Company size
11-50
Company stage
Series A
Total funding
$59.5M
Headquarters
Redwood City, CA
Founded
2018

Recently Posted Jobs

Explore more opportunities at Earli

See more jobs